Copyright: ©Author(s) 2026.
World J Stem Cells. Mar 26, 2026; 18(3): 116226
Published online Mar 26, 2026. doi: 10.4252/wjsc.v18.i3.116226
Published online Mar 26, 2026. doi: 10.4252/wjsc.v18.i3.116226
Table 1 Components of exosomes structure
| Serial number | Structure | Compositions | Functions |
| 1 | Cytoskeletal elements | Actin, tubulin, cofilin, talin, vimentin | Structural support, vesicle formation, transport |
| 2 | Lysosomal protein | Lamp2b | Degradation, protein sorting, membrane trafficking |
| 3 | Exosome membrane | Sphingomyelin, phosphatidylserine, cholesterol, and ceramides | Encloses exosomal content, interacts with target cells |
| 4 | Tetraspanin family | CD63, CD9, CD37, CD81, and CD82 | Membrane organization, protein interactions, cell adhesion |
| 5 | HSPs | HSP70, HSP90, HSP20, HSP27, HSP60, HSC70 | Protein folding, stress response, cell protection |
| 6 | Intercellular adhesion molecule | ICAM-1, integrins, p-selectin, lactadhesion | Cell-cell interactions, signaling, immune responses |
| 7 | Fusion and membrane transport proteins | GTPases, flotillin, annexins, Rabs, dynamin, syntaxin | Vesicle fusion, content release, membrane trafficking |
| 8 | Transmembrane proteins | CD13, LAM1/2, PGRL | Signaling, cell-cell interactions, membrane anchoring |
| 9 | Immuno-regulator molecules | CD80, CD86 | Modulate immune responses, tolerance, inflammation |
| 10 | Antigen presentation | MHC class I and II molecules | Activate immune cells, antigen display |
| 11 | Nucleic acids | mRNA, DNA, and non-coding RNAs | Genetic information transfer, gene regulation |
| 12 | Enzymes | Glycosidases, GAPDH, nitric oxide synthase, catalase, phosphatases, lipases, pgk1, ATPase | Catalyze biochemical reactions, metabolic processes |
| 13 | Growth factors and cytokines | TRAIL, TNF-α, TGF-β | Cell growth, differentiation, signaling |
| 14 | ESCRT-dependent exosomal biogenesis | ALIX, TSG101, clathrin | Exosome formation, sorting, release |
Table 2 Neuroregenerative effects of exosomes
| Mechanisms | Functions | Effects |
| Neurotransmitter release | Exosomes release neurotransmitters, promoting neuronal communication | Enhanced synaptic plasticity, cell survival |
| Cellular communication | Exosomes facilitate communication between neurons, oligodendrocytes, and microglia | Regulation of cellular processes, neuroprotection |
| Epigenetic control | Exosomes influence gene expression, regulating neurogenesis and neuroinflammation | Modulation of neuroregenerative processes |
| Synaptic plasticity | Exosomes promote synaptic strengthening, neuronal adaptation | Improved cognitive function, memory |
| Neuroprotection | Exosomes transfer protective signals, enhancing cell survival | Reduced neuroinflammation, oxidative stress |
| Calcium influx regulation | Exosomes modulate calcium influx, regulating neuronal excitability | Maintenance of neuronal homeostasis |
| Serotonin-mediated release | Exosomes released via serotonin pathways, influencing mood regulation | Modulation of mood, cognitive function |
| Microglia activation | Exosomes from microglia regulate neuroinflammation, immune responses | Neuroprotection, reduced inflammation |
| Oligodendrocyte support | Enhance neuronal survival, myelination | Improved neuronal regeneration |
| Blood-brain barrier crossing | Facilitate neuroregeneration | Access to central nervous system for therapeutic interventions |
Table 3 Comparison of exosomes isolation methods
| Isolation method | Purity | Pros | Cons |
| Ultracentrifugation | Low | Widely used, simple protocol | Time-consuming, multi-step process, high contamination risk |
| Size exclusion chromatography | High | Fast, simple and low-cost | Subtyping involves significant sample sizes and another procedure |
| Immunoaffinity-based approaches | High | Does not require special equipment, enrich cell-specific exosomes by targeted surface markers | Relies on high-cost antibodies, time consuming |
| Polymer-based precipitation | Low-to-medium | Low-cost method, easy protocol | Contamination risk, high cost, time consuming |
| Microfluidic devices | Low | Does not require special equipment, cost-effective | Design complexity |
| Nanotechnology | High | Commercially obtainable nanowires | High cost, restricts sample size |
- Citation: Choudhery MS, Arif T, Mahmood R, Harris DT. Stem cell derived exosomes: Emerging cell-free therapeutics for neurodegenerative disorders. World J Stem Cells 2026; 18(3): 116226
- URL: https://www.wjgnet.com/1948-0210/full/v18/i3/116226.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v18.i3.116226
